Dr. Douglas D. Martin, MD

Dr. Martin practices at OSU Radiation Oncology in Columbus, Ohio.

Dr. Martin's NPI, 1811915291, was assigned on July 17, 2006. Dr. Martin graduated from Sanford School of Medicine in 1987. Dr. Martin holds Ohio license 35088880.

Dr. Martin's primary practice is OSU Radiation Oncology, at 460 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-8415.

Dr. Martin's primary practice is OSU Radiation Oncology in Columbus, Ohio. Dr. Martin is also affiliated with Ohio State University Hospital. The medical group on file is Holzer Health System. Dmand AI also links Dr. Martin to 2 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Martin practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Martin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Martin is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Martin's licenses on file in 8 states: Ohio, California, Kentucky, North Carolina, Virginia, Delaware, Iowa and Louisiana.

Dmand AI lists bladder cancer radiation, bone cancer radiation, head & neck cancer radiation, prostate cancer radiation and uterine cancer radiation among the conditions Dr. Martin treats.

CMS data shows 1,087 Medicare services from Dr. Martin across 14 procedure codes in 2024, for 193 Medicare patients. Medicare paid $70,484 for them.

CMS counts 193 Medicare patients who saw Dr. Martin in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have cancer, and 72% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Martin's median patient age at 71, with 13% women.

In 2024, Dr. Martin wrote 65 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 42 of them, across 1 drug with 11 or more claims each, at $374 in total drug cost. In 2023, CMS named 71 claims across 1 drug.

Dr. Martin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 30 papers to Dr. Martin, published from 2009 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Prostatic Neoplasms, Brachytherapy and Prostatectomy. Dr. Martin has published most often in Brachytherapy. Dr. Martin's most frequent co-authors are Allison Marie Quick, MD, Alexander Christopher Yaney, MD and Erin Heather Healy, MD.

Dmand AI links Dr. Martin to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Urinary Bladder Neoplasms and Prostatic Diseases.

Dmand AI lists 5 awards for Dr. Martin, most recently Castle Connolly Top Doctor award in 2020.

Dr. Martin graduated from Sanford School of Medicine in 1987.

Dr. Martin is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.